ARCHIVES

Clinical Trials Approved By NCI CTEP During July

This article is from The Cancer Letter archive.

Vol. 25 No. 8 | August 30, 2002

Download PDF Visit The Full Archive

Related Articles

Treatment Progress Increases Five Year Survival To 41%; Rates Compared For 10 Leading Cancers

April 25, 1980

Tamoxifen Trial Enrolls 19% Of Women Needed, Fisher Reports To NCAB

October 16, 1992

Bypass Budget for FY 1989 to Ask $2 Billion For NCI, With Projection To $3 Billion by 1993

May 29, 1987

BMS, ImClone To Develop New Drug IMC-C225, Targets EGF Receptor.

September 28, 2001

Reversing Policy On Cancer Control Research, New Center Guidelines Top Accomplishments, Terry Believes

August 21, 1981

House Still Sees Problems In NIH Financial Management

July 5, 1991